Step 1 topics → Immunology → Type III Hypersensitivity (Immune Complex)

Type III Hypersensitivity (Immune Complex)

USMLE Step 1 trap: Attributes Type III tissue injury to direct MAC lysis rather than neutrophil-mediated damage triggered by complement anaphylatoxins. In Type III hypersensitivity, immune complexes deposit in vessel walls and tissues, activate complement generating C3a/C5a (anaphylatoxins), recruit neutrophils, and neutrophil degranulation causes the tissue damage — not direct MAC lysis.

Type III hypersensitivity is the immune complex (IC) disease mechanism — antigen-antibody complexes form in circulation or deposit in tissues, trigger complement, recruit neutrophils, and cause local tissue destruction. USMLE Step 1 tests this at multiple levels: you need to know the mechanistic pathway (formation → deposition → complement activation → neutrophil recruitment → tissue damage), recognize the classic diseases by their clinical fingerprints, and distinguish the localized Arthus reaction from systemic diseases like serum sickness. The diseases on this topic are high yield across both basic science and clinical vignette formats.

What makes this concept tricky is that students blur the mechanisms across hypersensitivity types. The complement system is involved in both Type II and Type III, so students often attribute the wrong effector mechanism to Type III — assuming MAC-mediated lysis does the damage when it's actually neutrophil degranulation after C3a/C5a-driven recruitment. The timing confusion is also classic: serum sickness looks almost nothing like anaphylaxis clinically, but students anchor on 'immune response = fast' and forget the 7–10 day lag needed to build enough IgG-antigen complexes.

On USMLE Step 1, you'll encounter this as direct mechanism questions ('which cells mediate the tissue injury?'), disease recognition vignettes (fever + arthralgias + rash after drug exposure, or hematuria after strep infection), and passage-based questions where you need to map an experimental immune complex setup onto the correct hypersensitivity type and effector pathway. Nail the mechanism cold, then map the diseases onto it.

From real student decks
70%have cards covering this topic
46%have mature cards

Common misconceptions

Common mistake
Wrong: Type III hypersensitivity causes tissue damage directly through complement membrane attack complex lysis of cells.
Right: In Type III hypersensitivity, immune complexes deposit in vessel walls and tissues, activate complement generating C3a/C5a (anaphylatoxins), recruit neutrophils, and neutrophil degranulation causes the tissue damage — not direct MAC lysis.
The membrane attack complex (MAC) does get generated when complement activates in Type III — but MAC lyses cells, and the target in Type III is the vessel wall and surrounding tissue, not a pathogen or antibody-coated cell. The real damage comes from C3a and C5a (anaphylatoxins), which recruit and activate neutrophils to the deposition site. Those neutrophils degranulate, releasing proteases and reactive oxygen species that destroy local tissue. Think of complement as the alarm system and neutrophils as the wrecking crew.
Common mistake
Wrong: Serum sickness symptoms appear immediately after antigen exposure, like Type I hypersensitivity.
Right: Serum sickness (Type III) symptoms appear 7–10 days after antigen exposure, the time required to form sufficient IgG–antigen immune complexes that deposit in tissues.
Serum sickness is a Type III reaction, not Type I — the body needs time to mount a full IgG response against the foreign antigen (classically a drug or foreign protein), form circulating immune complexes, and deposit them in vessel walls. That process takes 7–10 days. Type I (anaphylaxis) is fast because IgE is already sitting on mast cells waiting for re-exposure; no new antibody production is needed. If a vignette describes fever, arthralgias, and urticaria appearing a week after drug exposure, think serum sickness, not anaphylaxis.
Common mistake
Wrong: The Arthus reaction is a systemic immune complex disease like serum sickness.
Right: The Arthus reaction is a localized Type III hypersensitivity reaction occurring at the site of antigen injection in a pre-immunized individual, causing local vasculitis and necrosis, in contrast to the systemic immune complex deposition of serum sickness.
The Arthus reaction requires that the individual already has circulating IgG antibodies against the antigen (pre-immunized). When the antigen is injected locally (e.g., a booster vaccine in someone with high pre-existing titers), immune complexes form right at the injection site, deposit in local vessel walls, and cause localized vasculitis and necrosis — the pathology stays put. Serum sickness is the opposite scenario: large amounts of foreign antigen flood the circulation, complexes form systemically, and they deposit wherever hemodynamic conditions favor it (glomeruli, joint spaces, vessel walls throughout the body). Local vs. systemic deposition is the key distinguishing feature.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Trace the full mechanistic sequence of Type III hypersensitivity: how immune complexes form, where they deposit, how complement gets activated, and which effector cells actually cause tissue damage (neutrophils, not MAC).
  2. Identify the classic Type III immune complex diseases — serum sickness, post-streptococcal glomerulonephritis, SLE, polyarteritis nodosa, rheumatoid arthritis — and recognize their distinguishing clinical and histopathologic features.
  3. Distinguish the Arthus reaction (localized, at injection site, pre-immunized individual) from systemic immune complex diseases like serum sickness, and explain why each presents differently.

Can you avoid these mistakes?

A patient develops fever, diffuse arthralgias, and urticaria 8 days after starting a new antibiotic. Complement levels are low. What is the sequence of events that led to tissue injury in this condition — specifically, which cells are the proximate cause of damage and how were they recruited?
A researcher injects an antigen subcutaneously into a rabbit that was immunized with the same antigen three weeks earlier. Within 4–8 hours, the injection site becomes red, swollen, and hemorrhagic. Which hypersensitivity type is this, and how does it differ mechanistically and anatomically from serum sickness?
On electron microscopy of a renal biopsy from a patient with post-streptococcal glomerulonephritis, you see subepithelial 'humps.' Immunofluorescence shows granular ('lumpy-bumpy') IgG and C3 deposits. Why does this pattern of deposition look granular rather than linear, and which complement products are responsible for recruiting the effector cells?
A student argues that the tissue necrosis in the Arthus reaction is caused by the membrane attack complex directly lysing endothelial cells. What is wrong with this model, and what is the correct effector mechanism?

Related topics

Immunoglobulin Structure and Isotypes Thymus and T Cell Maturation Spleen Architecture and Function Lymph Node and MALT Architecture Innate Immune Cells Overview

See how your Anki deck covers this topic.

Upload your deck for a free audit →